» Articles » PMID: 36902772

Management of Stable Vitiligo-A Review of the Surgical Approach

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Mar 11
PMID 36902772
Authors
Affiliations
Soon will be listed here.
Abstract

At present, vitiligo is the most common depigmenting skin disorder, characterized by clearly demarcated discolored patches of various shapes and sizes. Depigmentation results from the initial dysfunction and subsequent destruction of melanin-producing cells, called melanocytes, which are located in the basal layer of the epidermis and in hair follicles. This review concludes that the extent of repigmentation, regardless of the treatment method, is greatest in stable localized vitiligo patients. The aim of this review is to provide an overview of the clinical evidence for which the vitiligo treatment method (cellular or tissue) is more effective. The treatment relies on multiple factors, ranging from patient skin predisposition for repigmentation to the experience of the facility performing the procedure. Vitiligo is a significant problem in modern society. Although it is a typically asymptomatic and not life-threatening disease, it may have significant psychological and emotional impacts. Standard treatment relies on pharmacotherapy and phototherapy; however, the treatment of patients with stable vitiligo varies. The stability of vitiligo more than often implies the exhaustion of the potential for skin self-repigmentation. Thus, the surgical methods that distribute normal melanocytes into the skin are crucial elements of these patients' therapy. The most commonly used methods are described in the literature, with an indication of their recent progress and changes. In addition, information on the efficiency of the individual methods at specific locations is compiled in this study, and the prognostic factors indicating repigmentation are presented. Cellular methods are the best therapeutic option for large-sized lesions; although they are more exorbitant than tissue methods, they benefit from more rapid healing times and presenting fewer side effects. Dermoscopy is a valuable tool used to assess the further course of repigmentation, where it is of great value to evaluate the patient prior to and following an operation.

Citing Articles

Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle.

Zhou Y, Zhang Y, Xiong Y, Li Y Front Med (Lausanne). 2025; 11:1510363.

PMID: 39882529 PMC: 11775757. DOI: 10.3389/fmed.2024.1510363.

References
1.
Bhingradia Y, Patel N . Pinhole technique for cobblestoning in patients post mini-punch grafting for stable vitiligo. Indian J Dermatol Venereol Leprol. 2021; 87(6):861-863. DOI: 10.25259/IJDVL_397_20. View

2.
Alikhan A, Felsten L, Daly M, Petronic-Rosic V . Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011; 65(3):473-491. DOI: 10.1016/j.jaad.2010.11.061. View

3.
Lamoria A, Agrawal A, Rao P, Kachhawa D . A Comparative Study between Follicular Unit Transplantation and Autologous Non-cultured Non-trypsinized Epidermal Cells Grafting (Jodhpur Technique) in Stable Vitiligo. J Cutan Aesthet Surg. 2020; 13(3):204-209. PMC: 7646426. DOI: 10.4103/JCAS.JCAS_189_19. View

4.
Abdel-Malek Z, Jordan C, Ho T, Upadhyay P, Fleischer A, Hamzavi I . The enigma and challenges of vitiligo pathophysiology and treatment. Pigment Cell Melanoma Res. 2020; 33(6):778-787. DOI: 10.1111/pcmr.12878. View

5.
Esmat S, Bassiouny D, Saleh M, AbdelHalim D, Hegazy R, ElHawary M . Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo. Dermatol Ther. 2020; 33(3):e13368. DOI: 10.1111/dth.13368. View